Albert David Limited (ALBERTDAVD) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Albert David Limited ₹139, price ₹857, upside -83.7%, quality 47 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Albert David Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹445.47 – ₹1,688 · fair‑value band ₹105.93 – ₹172.98 · the ₹856.70 price screens above the ₹139.46 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Follow Albert David in your weekly email
Every Wednesday you see whether Albert David is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products.
Show more
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
Stock analysis
Albert David Limited (ALBERTDAVD) currently trades at ₹856.70, while our model-based Fair Value estimate is ₹139.46, 83.7% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of ₹459.65 per share, and 0 of the 4 models we run sit above the ₹856.70 price.
Bear case: the Dividend Discount group reads lowest at ₹63.99, and 4 of the 4 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹105.93 (bear) to ₹172.98 (bull), the price of ₹856.70 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Albert David Limited reported revenue of ₹3.3B in FY2026 versus ₹3.1B in FY2022, a compound +1.7%/yr. Reported net income was −₹14.9M in FY2026.
Key figures
Market cap ₹4.9B (≈ $50.8M) · P/S ratio 1.21 · EPS (TTM) ₹−2.62 · Dividend yield 0.6% · Net margin −0.4% · Return on equity −0.4% · Return on assets (EBIT) 9.8% · Operating margin 0.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 5% below its 52-week high and 46% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at −84%, ALBERTDAVD screens richer than that median.
Fair Value models
Bear ₹105.93Fair Value ₹139.46Bull ₹172.98
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.20/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−3.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.3%
Start year 2021 (pandemic). Over 10 years: +0.4% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.4%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
5.3% (2021) → −1.3% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 599 stocks
Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score47 · Below median
Fair Value upside−83.7% · Bottom 25%
Profitability
Return on assets−0.5% · Below median
Net margin (TTM)−0.5% · Below median
Operating margin (TTM)0.0% · Below median
Growth and dividend
Revenue growth14.6% · Above median
Dividend yield (TTM)0.6% · Bottom 25%
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
P/S (TTM)0.02× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 16
FUTURE (revenue growth)73· sector 24
PAST (return on equity)0· sector 27
HEALTH (low debt)100· sector 96
DIVIDEND (yield)12· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Albert David Limited Fair Value". https://www.fairvalue-calculator.com/stock/ALBERTDAVD
Frequently asked questions
Is Albert David Limited (ALBERTDAVD) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹139.46 versus a price of ₹856.70, about −84% upside (overvalued).
What is the fair value of ALBERTDAVD?
Our model-based fair value for Albert David Limited is ₹139.46 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹856.70.
What is the quality score of ALBERTDAVD?
Albert David Limited has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Albert David Limited (ALBERTDAVD)?
Our model-based price target is the fair value of ₹139.46 (as of Sep 24, 2026) from 4 valuation models. Cautious scenario ₹105.93, optimistic scenario ₹172.98. It is a calculation from audited fundamentals, not an analyst target.
What is the Albert David Limited stock forecast for 2026?
Our models put fair value at ₹139.46, about −84% upside versus a price of ₹856.70 (overvalued). Cautious scenario ₹105.93, optimistic scenario ₹172.98. The calculation is refreshed regularly with new filings.
What is the revenue of Albert David Limited (ALBERTDAVD)?
Albert David Limited reported trailing-twelve-month revenue of about ₹3.3B (latest available figure, as of Sep 24, 2026).
Does Albert David Limited pay a dividend?
Albert David Limited currently shows a dividend yield of about 0.58% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Albert David Limited (ALBERTDAVD)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Albert David Limited it is ₹139.46 per share (as of Sep 24, 2026), against a price of ₹856.70. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is Albert David Limited stock overvalued or undervalued in 2026?
As of Sep 24, 2026, ALBERTDAVD trades above its calculated fair value: price ₹856.70, fair value ₹139.46, a gap of about −84% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ALBERTDAVD?
No. The price is what the market pays today (₹856.70); the fair value is what the company's own numbers justify (₹139.46). For Albert David Limited the two are ₹717.24 per share apart. That gap is exactly why we show both numbers side by side.
How much is Albert David Limited worth?
The market values Albert David Limited at about ₹4.9B (market capitalisation, as of Sep 24, 2026). Per share that is ₹856.70; our models calculate a fair value of ₹139.46 per share.
What do the bullish and bearish scenarios say about ALBERTDAVD?
Our models span a range for Albert David Limited: cautious scenario ₹105.93, base ₹139.46, optimistic ₹172.98 per share (as of Sep 24, 2026, price ₹856.70). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Albert David Limited (ALBERTDAVD)?
Balance-sheet figures for Albert David Limited (as of Sep 24, 2026): return on equity −0.4%, debt of 0.00 per unit of equity. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is ALBERTDAVD from its 52-week high?
Albert David Limited trades at ₹856.70, about 5% below its 52-week high of ₹898.60 and 46% above the low of ₹587.05 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹139.46 is for.
Which stocks are comparable to Albert David Limited?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Albert David Limited stock attractive at the current price?
The data as of Sep 24, 2026: price ₹856.70, calculated fair value ₹139.46 (−84%), Quality Score 47/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of ALBERTDAVD calculated?
We run Albert David Limited through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹139.46, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Albert David Limited itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Albert David Limited (ALBERTDAVD)?
The closing price on Oct 1, 2026 was ₹856.70. Our model-based fair value is ₹139.46, about −84% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Albert David Limited right now?
The price sits above even our optimistic bull case (₹172.98). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Albert David Limited (ALBERTDAVD) come from?
Earnings per share at Albert David Limited grew +7.7 % a year from 2015 to 2026. Broken into its drivers: revenue per share +1.4 %, EBIT margin +9.2 %, tax rate +0.7 %, residual (interest, one-offs) −3.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Albert David Limited
How large is the market capitalisation of Albert David Limited (ALBERTDAVD)?
The market capitalisation of Albert David Limited is ₹4.9B (≈ $50.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Albert David Limited (ALBERTDAVD)?
The price-to-sales ratio of Albert David Limited is 1.21 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Albert David Limited (ALBERTDAVD)?
Earnings per share at Albert David Limited are ₹−2.62. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Albert David Limited (ALBERTDAVD)?
The dividend yield of Albert David Limited is 0.6%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Albert David Limited (ALBERTDAVD)?
The net margin of Albert David Limited is −0.4% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Albert David Limited (ALBERTDAVD)?
The return on equity (ROE) of Albert David Limited is −0.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Albert David Limited (ALBERTDAVD)?
On an EBIT basis the return on assets of Albert David Limited is 9.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Albert David Limited (ALBERTDAVD)?
The operating margin of Albert David Limited is 0.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Albert David Limited (ALBERTDAVD)?
Revenue at Albert David Limited is growing +14.6% versus a year earlier (3y avg −0.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Albert David Limited (ALBERTDAVD)?
Earnings per share at Albert David Limited are growing −57.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Albert David Limited (ALBERTDAVD) generate?
The free cash flow of Albert David Limited is −₹351M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Albert David Limited (ALBERTDAVD) hold?
Albert David Limited holds more cash than debt, ₹30.6M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Albert David Limited in the live analysis
One click puts Albert David Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
